OncoPharm cover image

NAPOLI 3, POUT, & Ivosidenib - Azole DDIs

OncoPharm

00:00

Historical first-line regimens and where nalirifox fits

John reviews prior standards—gemcitabine, gemcitabine+nab‑paclitaxel, and FOLFIRINOX—and positions nalirifox relative to them.

Play episode from 01:12
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app